Befejeződött1/2. fázis
A study to see how well CVGBM vaccine works at different doses and how safe it is in patients who had surgery for glioblastoma or astrocytoma
Key facts
- Where
- Bonn, Essen, Frankfurt Am Main, Freiburg im Breisgau, Heidelberg, Leipzig, Mannheim, Munich, Regensburg és Tuebingen, NémetországSee the 10 sites
- Phase
- 1/2. fázis
Where in Németország
- Universitaetsklinikum Bonn AöRBonn, NémetországNo longer taking part
- Universitaetsklinikum Essen (AoR)Essen, NémetországNo longer taking part
- Goethe University FrankfurtFrankfurt Am Main, NémetországNo longer taking part
- Medical Center- University of FreiburgFreiburg im Breisgau, NémetországNo longer taking part
- Heidelberg University Hospital AöRHeidelberg, NémetországNo longer taking part
- Universitätsklinikum Leipzig AöRLeipzig, NémetországNo longer taking part
- Universitat HeidelbergMannheim, NémetországNo longer taking part
- Klinikum der Universitaet Muenchen AöRMunich, NémetországNo longer taking part
- Universitaetsklinikum RegensburgRegensburg, NémetországNo longer taking part
- Universitaetsklinikum TuebingenTuebingen, NémetországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Curevac AG
- Trial code
- EU 2022-501423-25-00
- Record updated
- 2025. szeptember 15.